Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
Macular Disease Foundation Australia (MDFA) is committed to understanding the impact of macular disease on the lives and health of people who live with the condition. One of the ways we do this is through our Social Impact research.
Professor Chandra Balaratnasingam’s MDFA-funded research is exploring the cellular changes that occur in diabetic macular ischaemia (DMI) to help develop a breakthrough therapy.
Grant Family Fund support is allowing Dr Alexis Ceecee Britten-Jones to research a way to ensure people with rare inherited macular dystrophies receive the right treatment for them in future.
Find out how the Grant Family Fund is helping Dr Xavier Hadoux use cutting-edge technology to detect the early signs of macular disease.
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government.
Spatial transcriptomics in diabetic macular ischaemia
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government
Composition and functionality of high-density lipoprotein in age-related macular degeneration and a high-risk disease phenotype
Redefining macular disease diagnosis to improve access to emerging therapies
Investigating mitochondrial dysfunction in macular degeneration – towards new treatments and biomarkers
Evaluating the potential of hyperspectral imaging for detecting and monitoring geographic atrophy Accurate monitoring of